COVID-19

This Company Is Giving Away Weed If You Get a COVID-19 Vaccine

As the COVID-19 pandemic rages on, one company is trying to encourage U.S. citizens to get vaccinated by offering them free cannabis. COVID-19 is once again surging throughout the ...

The Cannabis Industry's Biggest Wins of 2020

2020 was a year unlike any other, and this goes for the cannabis industry as well. So how did cannabis fare last year? When the coronavirus hit, the world was brought to a screech...

2020 Was a Record Year For Cannabis Sales in Colorado

Despite the COVID-19 pandemic, 2020 is already Colorado's best year for weed sales. From January through to October this year, Colorado dispensaries have already sold more marijuan...

MGC Pharma Receives $5 Million Cash Grant For ArtemiC Production in Malta

MGC Pharma will receive a $5 million cash grant to create a GMP-certified manufacturing facility for its novel treatment for COVID-19, ArtemiC. MGC Pharmaceuticals Ltd (ASX: MXC), ...

Study Finds CBD May Help COVID-19 Recovery

A new study shows that CBD could help to prevent extensive lung damage from COVID-19. A study published in the Cannabis and Cannabinoid Research Journal found that pure CBD can ass...

The Oceania Cannabis Industry Could Be Worth $1.55B by 2024 – Prohibition Partners Report

A new report from Prohibition Partners has been released detailing the state of play for the burgeoning cannabis industry in the region of Oceania. Read this article for more infor...

Jamaican Government Approves Online Cannabis Sales

Medicinal cannabis patients will now be able to collect their orders from dispensaries as part of an effort to manage the coronavirus outbreak.The Jamaican Government has announced...

Applied Cannabis Research Launches Game-Changing Anxiety Study

The Coronavirus pandemic is causing stress levels to rise. Luckily, Applied Cannabis Research has launched a new study investigating the use of medicinal cannabis as a treatment fo...

MGC Completes Phase II Trial of COVID-19 Formula

MGC Pharma has concluded the Phase II Trial of its novel anti-inflammatory formula 'ArtemiC,' which is designed to treat patients suffering from COVID-19.MGC Pharmaceuticals Ltd (A...

MGC Pharma's COVID-19 Treatment Shows No Pathological Impact on Major Organs

MGC Pharmaceuticals' latest animal study on its novel COVID-19 treatment 'ArtemiC', revealed the formula causes "no pathological changes" in major organs.MGC Pharmaceuticals (ASX: ...